1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Pennsylvania >
  6. PharmAnalysis Group Acquires UBC

M&A Deal Summary

PharmAnalysis Group Acquires UBC

On August 9, 2004, PharmAnalysis Group acquired life science company UBC

Acquisition Highlights
  • This is PharmAnalysis Group’s 1st transaction in the Life Science sector.
  • This is PharmAnalysis Group’s 1st transaction in the United States.
  • This is PharmAnalysis Group’s 1st transaction in Pennsylvania.
Investment Fate
  • UBC was sold to a consortium of financial buyers in 2009.
  • UBC was sold to a publicly-traded strategic buyer in 2010 for 730M USD.
  • UBC was divested to a consortium of strategic buyers in 2013.
  • UBC was divested to a consortium of buyers in 2017.

M&A Deal Summary
Date 2004-08-09
Target UBC
Sector Life Science
Buyer(s) PharmAnalysis Group
Deal Type Add-on Acquisition

Target

UBC

Blue Bell, Pennsylvania, United States
UBC engages in the biopharmaceutical market which provides integrated clinical, safety, and commercialization services. UBC brings together renowned scientific research and operations experts with innovative technologies, allowing for the best patient and healthcare provider experience. UBC was founded in 2003 and is based in Blue Bell, Pennsylvania.

Search 215,074 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

PharmAnalysis Group

Alexandria, Virginia, United States
Category Company
Sector Healthcare Services
DESCRIPTION

PharmAnalysis Group, Inc. assists the pharmaceutical, biotechnology, and medical device industries with complex reimbursement issues.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Pennsylvania M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2004 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal